Digital Oncology

  Continuous multimodal wearable device monitors temperature, heart-rate and oxygen-saturation post–lung-cancer surgery A study investigated the feasibility and reliability of using a multimodal digital wearable device (a specialized smartwatch) combined with an Electronic Patient-Reported Outcomes (ePROs) system for continuous monitoring of patients undergoing thoracic surgery for lung cancer. The traditional episodic care model, based on periodic assessment, often misses intermittent or subtle signs of postoperative complications. This multimodal system tracked core vital signs—temperature, heart rate, and oxygen saturation—alongside patient feedback and activity metrics. The findings showed a high level of agreement between the wearable device's readings and traditional clinical measurements, validating the device's reliability. Crucially, the system demonstrated significant potential in outlier detection , flagging vital sign fluctuations that occurred between scheduled n...

A study investigated the feasibility and reliability of using a multimodal digital wearable device (a specialized smartwatch) combined with an Electronic Patient-Reported Outcomes (ePROs) system for continuous monitoring of patients undergoing thoracic surgery for lung cancer. The traditional episodic care model, based on periodic assessment, often misses intermittent or subtle signs of postoperative complications. This multimodal system tracked core vital signs—temperature, heart rate, and oxygen saturation—alongside patient feedback and activity metrics. The findings showed a high level of agreement between the wearable device's readings and traditional clinical measurements, validating the device's reliability. Crucially, the system demonstrated significant potential in outlier detection , flagging vital sign fluctuations that occurred between scheduled nurse rounds. This continuous monitoring approach is vital for achieving Enhanced Recovery After Surgery (ERAS) protocol...

A new international study evaluated the effectiveness of iDECO (Intelligent Digital Education Tool for Colposcopy) , an AI-driven platform designed to close critical training gaps in cervical cancer prevention globally. Traditional in-person colposcopy training is often inaccessible and expensive, particularly in low- and middle-income countries (LMICs). The iDECO platform addresses this by offering a bilingual, web-based course that integrates authentic clinical cases, gamified learning modules, and personalized analytics. The study, involving nearly 400 clinicians from countries including China, Mexico, and Mongolia, demonstrated marked improvements in performance. Participants' diagnostic accuracy increased significantly (with an odds ratio of 1.72), and their ability to detect high-grade lesions more than doubled. Clinicians from lower-resource settings showed the greatest gains, highlighting the tool’s potential to equalize training standards across regions. The platform...

Researchers at Yale School of Medicine have developed a groundbreaking "Google Maps" approach for analyzing Non-Small Cell Lung Cancer (NSCLC) tumors. This new method combines Artificial Intelligence (AI) with spatial biology to create detailed, cell-by-cell maps of tumors across multiple cohorts in the U.S., Europe, and Australia. The approach aims to predict how specific regions or "neighbourhoods" within a tumor will respond to different therapies, rather than treating the tumor as a single entity. The mapping technique identifies areas that are both responsive and resistant to drugs like immunotherapy. Given that immunotherapy can cost hundreds of thousands of dollars and is effective in only 20-30% of patients, this tool is poised to be a game-changer for personalized treatment . By integrating data on a tumor’s molecular geography and immune environment with machine learning, oncologists can move away from trial-and-error, select the most effective treatmen...

A study published in Radiology evaluated the performance and false-negative rate (FNR) of AI models used for screening mammograms. The research confirmed that while AI is effective in detecting many invasive breast cancers, it is still prone to missing certain cases. The study found that AI missed 14% of cancers , with the highest FNR occurring in Hormone Receptor (HR)-positive cancers . The specific cancer characteristics that AI was more likely to miss included smaller size, lower grade, and location in dense breast tissue or outside typical mammary zones. The cancers missed by AI were often also the subtle findings missed by human radiologists. The findings suggest that relying solely on AI could lead to overlooked, clinically significant cancers. The conclusion supports the consensus that AI should be used as a "second reader" to augment and not replace radiologists, requiring clinicians to remain vigilant in areas where AI is known to underperform. Read the original ar...

A multi-center study developed and validated CerviPro , a deep learning-based multimodal prognostic model, aimed at predicting Disease-Free Survival (DFS) and recurrence risk for patients with Locally Advanced Cervical Cancer (LACC) receiving definitive radiotherapy. The model integrates diverse data sources: pre- and post-treatment CT imaging , handcrafted radiomic features , and clinical variables (such as patient demographics and tumor size). The CerviPro model significantly outperformed traditional prediction methods (like FIGO staging alone) by consistently showing the synergistic value of integrating multimodal features. The model's primary clinical value is its ability to identify patients at high risk of treatment failure before initiating therapy. This early prediction allows clinicians to deliver targeted, intensified treatments to high-risk individuals while sparing patients likely to respond well to standard care from unnecessary escalation. The robust performance ac...